The AVANZA Advisory Board
Ira S. DuBey, M.S., M.B.A. – Chairman of the Advisory Board
Mr. DuBey has over 25 years of senior executive experience managing and building science based businesses. Currently, Ira is Executive Vice President and Chairman of the Advisory Board for AVANZA Laboratories LLC. In this capacity, he is responsible for the management of the BioPharmaceutical Services business and continued growth strategy of AVANZA and in ensuring that there is the appropriate alignment between scientific expertise, operational excellence and business expansion into appropriate sectors. Read Biography
Patrick Bennett, M.S., M.B.A.
Patrick has over 25 years experience in pharmaceutical analysis. He started his career with SmithKline Bioscience in 1985 in toxicology/drug testing. Read Biography
Yale H. Caplan, Ph.D., D-ABFT
Dr. Yale H. Caplan received his Bachelor’s degree in Pharmacy (1963) and Ph.D. degree in Medicinal Chemistry (1968) from the University of Maryland at Baltimore (School of Pharmacy). He is a Board Certified forensic toxicologist (American Board of Forensic Toxicology). Read Biography
Edward Jackson Cone, Ph.D.
Edward J. Cone received his B.S. in chemistry from Mobile College in 1967 and his Ph. D. in organic chemistry in 1971 from the University of Alabama. Presently, Dr. Cone is serving as a consultant to private industry and various government agencies on matters relation to the standardization of drug testing methodologies and drug surveillance systems. Read Biography
Marian Kelley, M.A.
Marian Kelley received her B.A. in biology in 1970 from Gwynedd Mercy College and her M.A. in biology in 1974 from West Chester State University. Kelley worked at J&J PRD and Centocor, J&J’s Biotech facility for over 12 years before forming MKelley Consulting LLC. Read Biography
Thomas A. Kubic, J.D., Ph.D.
Dr. Thomas A. Kubic holds a Ph.D. with a concentration in Forensic Science from C.U.N.Y., a Masters Degree in Chemistry from Long Island University and a Law degree from St. John’s University. Read Biography
Sidney Pestka, M.D.
Dr. Pestka is known as the “Father of Interferon” for his seminal work on interferon that gave birth to what is, today, a $6 billion dollar market directed at the therapy of hepatitis, multiple sclerosis, cancer, and other diseases that affect mankind. He was the first to purify interferon, the first to clone mature interferons and the first to develop a commercialized recombinant biotherapeutic—interferon alpha. Many of his achievements have broad application in the biotechnology and pharmaceutical industries. Pestka graduated summa cum laude with a B.A. in chemistry from Princeton University (1957) and received his medical degree from the University of Pennsylvania School of Medicine (1961). Read Biography
Kory Engelke, Ph. D., D.A.B.T.
Dr. Engelke received his PhD in Pharmacology and BS in Biochemical Sciences from the University of Vermont and is a Diplomate of the American Board of Toxicology. Read Biography